Charles River recently announced plans to acquire WIL Research, a premier provider of safety assessment and contract development and manufacturing services to biopharmaceutical, agricultural and industrial chemical companies worldwide.
Additionally, in the fourth quarter of 2015, Oncotest, a Germany-based contract research organization providing discovery services for oncology, became part of the Charles River portfolio.
According to Charles River, these acquisitions deliver additional scientific capabilities and access to global markets to better serve its customers.
Kirsty Doolan 12 February 2025 We examine what's new in tropical and ingestible beauty products…
10 February 2025 IFF announces the launch of its new artificial intelligence (AI)-powered search tool:…
Renata Martins 6 February 2025 The global cosmetics market is evolving rapidly with an influx…